Research programme: vaccines - Beijing Minhai Biotechnology

Drug Profile

Research programme: vaccines - Beijing Minhai Biotechnology

Alternative Names: DTaP-Hib-sIPV combined vaccine - Beijing Minhai Biotechnology; EV71 vaccine - Beijing Minhai Biotechnology; H1N1 influenza vaccine - Beijing Minhai Biotechnology; H7N9 influenza vaccine - Beijing Minhai Biotechnology; Herpes simplex vaccine - Beijing Minhai Biotechnology; Human papillomavirus vaccine quadrivalent - Beijing Minhai Biotechnology; Meningococcal vaccine group B - Beijing Minhai Biotechnology; MR and Varicella vaccine - Beijing Minhai Biotechnology; Mumps vaccine - Beijing Minhai Biotechnology; Rotavirus vaccine 5-valent - Beijing Minhai Biotechnology; Varicella vaccine - Beijing Minhai Biotechnology; Zoster vaccine - Beijing Minhai Biotechnology

Latest Information Update: 03 Sep 2015

Price : $50

At a glance

  • Originator Beijing Minhai Biotechnology
  • Class Bacterial vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Diphtheria; Enterovirus A infections; Haemophilus infections; Herpes simplex virus infections; Human papillomavirus infections; Influenza A virus H1N1 subtype; Influenza A virus H7N9 subtype; Measles; Meningococcal group B infections; Mumps; Pertussis; Poliomyelitis; Rotavirus infections; Rubella; Tetanus; Varicella zoster virus infections

Most Recent Events

  • 03 Sep 2015 Preclinical trials in Varicella zoster virus infections (Prevention) in China (Parenteral) before September 2015
  • 03 Sep 2015 Preclinical trials in Tetanus (Prevention) in China (Parenteral) before September 2015
  • 03 Sep 2015 Preclinical trials in Rubella (Prevention) in China (Parenteral) before September 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top